SPEAKERS

  • Gianclaudio Floria

    Senior Director, Head of Global Pricing and Market Access

    Fresenius Kabi SwissBioSim

  • Alla Uhrlandt

    Director Strategic Pricing EMEA

    Janssen Pharmaceutical Companies of Johnson & Johnson

  • Scott Murrie

    General Manager, Global Pricing

    GE Healthcare

  • Alan Crowther

    President of Global Markets

    Alliance Life Sciences

  • Slobodan Farago

    Commercial Excellence Manager MDS Europe

    BD

  • Fabrizio Gianfrate

    Professor of Health Economics

    University of Ferrara, Luiss Business School Rome, Italy

  • Halima Benghabrit

    Global Pricing Head of Established Products

    Sanofi

  • Photo Daniel Cho

    Daniel Cho

    Director Marketing, Global Pricing & Competitive Portfolio Analytics

    Philips Healthcare

  • Maarten Van Baelen

    Market Access Director

    Medicines for Europe

  • George Boretos

    CMO

    Cube RM

  • Gulen Desteli

    Global Pricing Manager

    GE Healthcare

  • Özkan Tezgin

    Global FP&A Manager

    Leica Microsystems

  • Diar Fattah

    Associate Director of Medicines Optimisation

    NHS 

  • Reginald Lassagne

    Director, Global Pricing

    LivaNova

  • Libor Minichbauer

    Head of Pricing & Payer Pro

    Novartis Oncology Region EGM

  • Ruven Remo Eul

    Director, Life Sciences

    HighPoint Solutions

  • Jörg Mahlich

    Head of Health Economics and Outcomes Research

    Janssen pharmaceutical

  • Mukarram Bhaiji

    Director, Global Pricing Strategy

    Smith & Nephew

  • Marc Abels

    Partner

    Monitor Deloitte Belgium

  • Dr. Marco Rauland

    Vice President MAP GM&E and Training Academy

    Merck KGaA

  • Gabriel Benthall

    Global Pricing Manager

    UCB

  • Adam Plich

    Vice President, Pricing & Market Access Europe

    Teva Specialty Medicines, Netherlands

  • Gary Watson

    Executive Vice President

    Alliance Life Sciences

  • Vinciane Knappenberg

    Reimbursement Procedures Coordinator

    National Institute for Health and Disability Insurance (RIZIV INAMI)

  • Mondher Toumi

    Professor Department of Public Health Research Unit

    Aix Marseille University

  • Luca Morreale

    Senior Manager Life Sciences

    HighPoint Solutions

  • Paolo Correale

    Director, Leader of Tefen Life Sciences Pricing Practice

    Tefen Management Consulting

  • Antonio Pregueiro

    VP Life Sciences Europe

    HighPoint Solutions

  • Ben Desmet

    Senior Manager

    Monitor Deloitte Belgium


Thank you for joining
the 8th EPP Life Sciences Pricing Forum
Relive it now!

 

 

 

 

Where Pharma and Medtech
Pricing & Market Access Leaders Meet

The 8th annual EPP Life Sciences Pricing Forum was a big success in 2018. We had a full house of Pricing and Market Access senior executives and innovators who learnt and discussed the biggest trends and developments in the Pharma and MedTech pricing and profit optimisation area.

We covered the most up to date pricing and market access real-world insights, payers’ strategies, new pricing models and  technology trends. The forum had more than 30+ senior industry speakers from companies such as Novartis, GE Healthcare, Sanofi, Philips, NHS/NICE, BD, Janssen, Smith & Nephew and many more sharing best practices and real case studies.

Our goal was to provide the most interactive and pioneering content forum, deeply detailed, in a setting with industry peers where attendees were able to network, learn and discuss about pricing strategy, payers’ relationships, price policy and innovative pricing tools. The forum offered 3 interactive days with exclusive case study presentations, 4 ground-breaking workshops, 6 round tables discussions & 3 panel sessions discussions and a great evening event and many more networking activities.

 

Looking for the presentations?

A large amount of information was presented during the 8th EPP Life Sciences Pricing Forum. We can look back on 3 days filled with high level expert presentations.

We have brought together all the material in the EPP content area, for download now, or possibly later.*

Click here and find the matieral that you find interesting.

*for EPP members only

 

 

 

If you are an influencer or specialize in pricing based on AI, machine learning – or agile pricing strategies in a digital world – we want to hear from you !

If you would like to contribute to this unique forum,
please contact Mariana Flores at mariana.flores@pricingplatform.eu

          

                                                                                                                                                              

 


If you would like to be part of this amazing forum next year : please contact us: 
mariana.flores@pricingplatform.eu or  britt.dejager@pricingplatform.eu or just give us call +32(0)473.71.76.69 


5 reasons why you should attend the EPP Life Sciences Pricing Forum in 2019 

  1. 120+ senior level executives come together for exclusive keynote presentations, innovative workshops, 2 breakouts on Pharma and MedTech, roundtables discussions and unrivalled networking to engage in high level business discussions that will shape the future of pricing and market acces
  2. The forum agenda was created together with key industry influencers to include the main industry’s challenges and opportunities
  3. 25+ Speakers delivering interactive workshops, roundtables, panel discussions and ground-breaking presentation
  4. Pharma & MedTech Breakouts: Discuss, learn and challenge both strategic and tactical topic
  5. Networking: Face-to-face conversations with top industry experts and your pricing peers during the innovative and interactive forum format – you will meet and do business with the leading industry leaders

Who will be attending?

Every year 120+ medtech and pharma attendees gather to discuss and reflect on the latest pricing and market access trends, learn about best business practices and meet world’s best experts in pricing and profit optimisation.

The EPP Life Sciences Pricing Forum brings together leading practitioners and experts to discuss, reflect, network and share. The forum is tailored for key stakeholders such as: Pricing, Reimbursement, Market Access, Commercial, Marketing and Sales Directors and VPs, CEOs and General Managers.

Download the forum brochure (button in top navigation) today to see the full speaker faculty and programme 

ATTENDING WITH 2+ GROUP : contact: mariana.flores@pricingplatform.eu or  britt.dejager@pricingplatform.eu or call +32(0)473.71.76.69.


This is an event you must attend!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

THE PROGRAMME

We are working on the upcoming programme 2019.

If you want to keep updated, please request the brochure (see top right in navigation).  As soon as the new brochure is available, we will send you the programme !

October 3rd 2019
08:00 Registration and networking coffee Hosts - EPP
08.40 Welcome Pol Vanaerde, President - - EPP
October 4th 2019
8:30 Enjoy a good cup of coffee -

Contact Forum Producer

Mariana Flores

PRE FORUM WORKSHOPS

Interested in delivering a Workshop ?

This can be your space to tell the industry about your innovative solutions and products.
Contact Mariana Flores : e: mariana.flores@pricingplatform.eu -/ m : +44 7792 905 223

SPEAKERS

We are proud to announce already a great line-up of experienced speakers for 2018 !!

If you would like to join the speaker faculty, please contact Mariana Flores: mariana.flores@pricingplatform.eu

Gianclaudio Floria

Senior Director, Head of Global Pricing and Market Access

Fresenius Kabi SwissBioSim

Currently leading Pricing and Market Access for Fresenius Kabi Biosimilars Business Unit, Gianclaudio Floria spent the last 15 years of his career in fast growing companies like Gilead Sciences and Amgen in different roles at country, regional and global level. He started his career in Finance and M&A, and moved on to SFE, Market Research, Business Analytics, and – for the last 10 – years Pricing and Market Access.

Alla Uhrlandt

Director Strategic Pricing EMEA

Janssen Pharmaceutical Companies of Johnson & Johnson

Alla is responsible for innovative pricing & access models, regional pricing infrastructure, capabilities and processes across the entire Janssen’s portfolio in the region. Throughout the 16 years of her career, she has broad experience in Pricing, Commercial Excellence, Sales and Technical Marketing in Europe and the USA. With extensive experience in value based pricing & innovative contracting, she has a long track record of developing and implementing commercialization strategy across the Pharmaceutical and Medical Device industry.

Scott Murrie

General Manager, Global Pricing

GE Healthcare

Scott is responsible for the strategic pricing of GE Healthcare’s portfolio and has over 20 years of experience in pricing.  He joined GE Healthcare in 2006 and held leadership positions in Market Access and Global Pricing.  Prior to GE, Scott served in several pricing and product management roles in the telecommunications industry.  Scott holds a PhD in Economics from Oklahoma State University and a BBA in Economics from The University of Oklahoma.  In addition, Scott completed the Oxford Strategic Leadership Program at the Saïd Business School, University of Oxford.

Alan Crowther

President of Global Markets

Alliance Life Sciences

Alan Crowther is President of Global Markets of Alliance Life Sciences, responsible for overseeing the Global Pricing solutions for Alliance. He brings 20 years of leadership, consulting and technology experience with him to the position. Alan has previously held roles as CEO at Alliance; founder of Adjility Health, a firm focused on life sciences analytical software; Vice President at Capgemini; Co-founder and Officer at Adjoined Consulting, where he ran the Life Sciences practice and was part of the leadership of the venture-backed company and helped drive it to a successful $200MM+ exit. Prior to Adjoined, Mr. Crowther was head of services for a small software company that exited to BEA Systems; and was a manager at Andersen Consulting (Accenture) before that. He is a graduate of Princeton University.

 

Slobodan Farago

Commercial Excellence Manager MDS Europe

BD

20 years plus of business and team leadership experience in life sciences (Life Sciences/Pharmaceuticals/Diagnostics/MedTech/Biotech). Well-proven in strategic roles (HQ) with leading industry players and consulting agencies. Value and solution driven mindset. Education background in biological sciences, management and business administration, and pricing. Strong expertise in Commercial Excellence, Sales Force Effectiveness, Business Analytics, Strategic Pricing, Marketing. People management and team leadership routine.

Fabrizio Gianfrate

Professor of Health Economics

University of Ferrara, Luiss Business School Rome, Italy

Phd and Masters in Health Economics (Rome, Stockholm, York). Master in Economic Journalism.

Full Professor of Health Economics, Market Access Consultant, Columnist. Ex-payer as AIFA member (pricing and reimbursement committee), Regional HTA Committees member (several Regions), Director at Ministry of Health (appointed), General Manager and Vice President of GSK Foundation Italy and of Angelini Foundation, several director roles in pharmaceutical industries, secondments in UK and US.

Past: Director of several magazines on healthcare and pharma, formers member of Farmindustria, Assobiotech, CENSIS, EFPIA, Federfarma.
Actual: Board Member of Italian Society of Pharmacoeconomics and Ethicals and Italian society of Healthcare studies).
Author of more than 700 articles and 7 books.

Halima Benghabrit

Global Pricing Head of Established Products

Sanofi

With more than 20 years’ experience in the pharma industry, Halima worked for several European and US companies. She has an extensive experience in marketing, mainly in cardio-vascular, CHC and diabetes areas at country and global level.

She moved 7 years ago to a global market access role before heading market access for emerging markets.

Currently Halima is leading global pricing management for established products. Her team is also in charge of implementing a new global price management tool deployed WW for the whole Sanofi portfolio as well as developing pricing analytics to optimize pricing execution and visibility.

 

 

Photo Daniel Cho

Daniel Cho

Director Marketing, Global Pricing & Competitive Portfolio Analytics

Philips Healthcare

Daniel is the head of a Global Pricing team of 10 which spans in USAndover and Germany Boeblingen, serving the business need forusing pricing as a tool to optimize margin and profitability for a 2.7BEuro business with Philips Healthcare. Daniel and his team built anextensive BI platform based on the Qlikview platform and provide1500+ users daily access to actionable intelligence from CRM (SF.com), OIT, Sales, Margin, Pricing (From SOFON Quotation system+ SAP) and other business data such as Installed Base. Daniel andteam have proven records of reversing the price erosion for all business,helping to improve market business margins within one-year cycle, aswell as improving qualified funnels for high margin business within aquarter. Daniel also had global experience in Product Management,Market Intelligence, New Product Introduction, as well as SalesDevelopment for Asia Pacific and Sales & Marketing experiencefor Asia Pacific. Daniel was also a trained Management Consultantfrom PriceWaterhouse in Sydney. He is now located in BoeblingenGermany for the past 14 years.

Maarten Van Baelen

Market Access Director

Medicines for Europe

The goal of « Medicines for Europe » (formerly EGA) is to improve health by ensuring better access to treatment for patients in Europe and beyond.  As Market Access Director, the objective of Maarten’s team is to shape in the EU a dynamic and sustainable market situation that enables fast and fair pricing and reimbursement for generic, biosimilar and value-added medicines.

Maarten joined « Medicines for Europe » in 2011 as Medical Affairs Manager with responsibilities in the areas of fighting Falsified Medicines and Pharmacovigilance. In his life before the association, he worked in the pharmaceutical industry providing pharmacovigilance consultancy and in the medical device industry liaising with Key Opinion Leaders. He combined these roles while working weekends in a community pharmacy.

Maarten is a pharmacist by education and holds an MBA from “Solvay Brussels School of Economics and Management” and “École des Ponts Paris Business School”.

George Boretos

CMO

Cube RM

George is the CMO of Cube RM, a vendor of Revenue Management & Optimization solutions with specialization in CPQ and Tender Management software. He has more than twenty years of professional experience in managerial positions in product marketing, pricing, corporate strategy, and sales. He is also a seasoned data scientist, specialized in price optimization models, with numerous successful business forecasts and scientific publications to his name in prestigious scientific journals and publishers, such as Elsevier and Foresight. He is a member of the International Institute of Forecasters

Gulen Desteli

Global Pricing Manager

GE Healthcare

Gulen Desteli works as a Global Pricing Manager at GE Healthcare and leads global pricing initiatives to drive profitability in complex markets and institutionalize value based pricing. Desteli is a seasoned pricing professional with 12 years of strategic pricing experience in Healthcare, FMCG, Telecom and Software industries. She holds an MBA from the University of Virginia, Darden School of Business and an undergraduate degree in Economics from Bogaziçi University.

Özkan Tezgin

Global FP&A Manager

Leica Microsystems

Özkan is a professional for over 15 years with the experience spanning across Revenue Management, Pricing, Treasury, Controlling, and Commercial Finance. Having started at E&Y in advisory services, till today, he took both global and European responsibilities at several international companies including General Motors.

In his current role, Özkan drives growth and profitability results by identifying and analyzing revenue and optimization potentials in Leica Microsystems, which is one of the world leaders in microscopes and scientific instruments.

Diar Fattah

Associate Director of Medicines Optimisation

NHS 

A pharmacist and health economist, Diar leads on medicines use and optimisation, prescribing and the provision of pharmaceutical services within the Dartford, Gravesham & Swanley CCG. In addition, he sits on the National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee.  His work has been focused on combatting inappropriate polypharmacy with the use of healthcare data analytics.

Reginald Lassagne

Director, Global Pricing

LivaNova

Experienced manager with 14 years of expertise in international and cross-functional environments dedicated to value improvement with regular exposure to senior management and concrete track record in:
– Pricing management: Strategy, Business Modelling, Reporting, Research
– Entrepreneurial Spirit: starting new projects, like Pricing function, from scratch, full Governance set-up
– Tender management: Pretender Strategy, business modelling, coaching, Governance set-up
– Commercial strategy and negotiation B2C, B2B and B2G
– Purchasing management and cost reduction strategy
– Change management: several implementations of ERPs: SAP, BW and new structures

Libor Minichbauer

Head of Pricing & Payer Pro

Novartis Oncology Region EGM

Libor Minichbauer is heading pricing for Novartis Oncology Emerging Growth Markets unit. In his current role he is responsible for pricing and innovative pricing models in 80+ countries in Asia, Middle East, Africa and CIS. Libor has worked in the industry for the last 10 years, held various roles in development, health economics, and pricing. Prior to joining pharma, he has spent several years in consulting, and IT and finance industries. Libor obtained his MBA from DePaul University in Chicago. He also holds a Masters in International Trade and Diplomacy from the University of Economics in Prague and Masters in Pharmacoeconomics from Pompeu Fabra University in Barcelona.

 

Ruven Remo Eul

Director, Life Sciences

HighPoint Solutions

Ruven is a Director within the European Life Sciences team based out of Zug, Switzerland responsible for project oversight and delivery, resource management and solution development in the areas of Pricing, Contracting and Tendering. Ruven brings a background of industry experiences in large pharma from companies such as Pfizer and BMS where he worked in Commercial roles with a large focus on leading cross functional Tendering teams for Pfizer in Germany. While at HighPoint Solutions, Ruven has worked with emerging, mid-tier and large pharma on various Tendering and Contracting programs from policy and process assessments, outsourcing of business functions, software vendor evaluations and implementation of global programs. Additionally, Ruven has conducted the industry’s first Benchmarking Study on Tendering issuing 4 reports presenting the benchmarking results and developed HighPoint’s Tender Data Service THOR focusing on supporting the awareness & planning phase of Tendering while building Competitive and Pricing Intelligence. In parallel, Ruven has also worked deeply in global commercial effectiveness programs.

Jörg Mahlich

Head of Health Economics and Outcomes Research

Janssen pharmaceutical

Jörg Mahlich is head of Health Economics and Outcomes Research at Janssen pharmaceutical companies of Johnson and Johnson in Germany. In addition, he is lecturer of Health Economics at the Economics Department of the University of Vienna and research affiliate at the Düsseldorf Institute for Competition Economics (DICE) of the University of Düsseldorf, Germany. Previous to that he hold different positions in industry and consulting in Austria, Germany, and Japan. He is interested in global pharmaceutical economics and policy. Jörg graduated in economics from the University of Kiel, Germany and holds a doctoral degree in economics from the University of Vienna, Austria.

Mukarram Bhaiji

Director, Global Pricing Strategy

Smith & Nephew

Responsible for designing pricing strategy, policies and governance for Smith & Nephew globally.

Marc Abels

Partner

Monitor Deloitte Belgium

Marc has 17 years of experience in Go to market strategies and a deep expertise in pricing.  He leads the Strategy department (80 consultants) for Monitor Deloitte Belgium. He is one of the ‘pricing’ experts within Deloitte Europe and is a regular speaker on various pricing conferences (e.g. Professional Pricing Society and European Pricing Platform). His main industry focus is on Lifesciences (Pharma, MedTech) but he also has experiences in Manufacturing and Services. Main skills: – Optimization of pricing across product portfolio and channels (incl. resolution of channel conflicts) – Development and commercialization of new offerings (products & services)  – Commercial Excellence and Digital Transformation Programs – Transformations from ‘product’ selling towards ‘solution’ selling and being more customer centric.

Dr. Marco Rauland

Vice President MAP GM&E and Training Academy

Merck KGaA

Marco Rauland has more than 20 years of drug development, marketing, market research and pricing consulting experience in the pharmaceutical industry. Prior to joining Merck Marco was Vice President Europe of GfK’s Market Access practice. Before that Marco was the global head of the pricing, access and reimbursement practice of Genactis and Senior director of the pricing and reimbursement business unit at TNS Healthcare (now Kantar Group).

Marco is an expert in global pricing, listing and reimbursement strategy and has extensive experience in implementing pricing, access and reimbursement solutions at all stages of the product life cycle, from early product development to post-launch pricing strategies. He has developed the pricing, access and reimbursement strategy for product launches across numerous therapy areas and has in-depth knowledge of international country pricing & reimbursement systems. Marco studied Biochemistry and Pharmacology at the University of Cologne and holds a PhD in Natural Science.

Gabriel Benthall

Global Pricing Manager

UCB

Gabriel’s primary focus within the Global Pricing team is to facilitate UCB’s operational pricing governance so that pricing & patient access excellence is maintained across UCB’s entire branded portfolio. He is primarily responsible for managing, challenging and synthesising affiliate pricing business cases into long term forecasts for global review. In addition, he aids the effective development and implementation of global strategy by acting as a bridge between Global and Local.

Gabriel started his career as a scientist researching on various areas, including antibiotic resistance and CAR T cells, in both academia and industry. He graduated in Medical Sciences at University of Exeter Medical School (UK) and his Master’s in Drug Design at University College of London (UK).

Adam Plich

Vice President, Pricing & Market Access Europe

Teva Specialty Medicines, Netherlands

Adam Plich is a seasoned global executive with over 10 years of broad-based high-profile success throughout healthcare, growing sales and expanding margins with multi-million dollar impacts. He drives market access, product pricing and sales, along with operational strategy and innovation. Mr Plich has an unmatched reputation for architecting and delivering flawless product launch strategies, with over 10 launches only in the last 5 years. Mr Plich is known for negotiating complex deals, successfully engaging government agencies and insurers, and repeatedly getting favourable pricing results while advancing patient access. He enjoys developing high-performance cultures and transforming organisations. Mr Plich is a recognised authority in pharma, frequent speaker, industry representative and a university lecturer. He is a pharmacist by training with post-graduate degree in strategic marketing.

 

Gary Watson

Executive Vice President

Alliance Life Sciences

Gary Watson is a VP at Alliance Life Sciences Global Pricing practice. Gary oversees PriceRight, an enterprise Price Governance software.  Gary’s background is in management consulting. Earlier in his career, Gary led BearingPoint’s IT Transformation Solutions practice, focused on delivering innovative IT Management strategies, practices and technologies to help clients dynamically balance and manage IT investments, resources and quality with multiple business objectives.

Vinciane Knappenberg

Reimbursement Procedures Coordinator

National Institute for Health and Disability Insurance (RIZIV INAMI)

Vinciane is a pharmacist since 2000. Between 2000 and 2006 worked in pharmacies in Brussels and in Vilvoorde. Since 2006, is employed by the National Institute for Health & Disability Insurance (NIHDI), first as a file manager for the Commission for Reimbursement of Medicines, and then (since 2013) as what we call ‘reimbursement procedures coordinator’ for the Directorate Pharmaceutical Policy, which means the job is the coordination of the team of the department within the directorate that is responsible for all decision processes (reimbursement of medicines, nutrition, active ingredients, managed entry agreements,..).

Mondher Toumi

Professor Department of Public Health Research Unit

Aix Marseille University

About Mondher

Professor Mondher Toumi is M.D. by training, M.Sc. in Biostatistics, and in Biological Sciences (option pharmacology) and Ph.D. in Economic Sciences. Mondher Toumi is Professor of Public Health at Aix-Marseille University.

After working for 12 years as Research Manager in the department of pharmacology at the University of Marseille, he joined the Public Health Department in 1993. In 1995 he embraces a carrier in the pharmaceutical industry for 13 years.

Mondher Toumi was appointed Global Vice President at Lundbeck A/S in charge of health economics, outcome research, pricing, market access, epidemiology, risk management, governmental affairs and competitive intelligence.

In 2008, he founded Creativ-Ceutical, an international consulting firm dedicated to support health industries and authorities in strategic decision-making.

In February 2009 he was appointed Professor at Lyon I University in the Department of Decision Sciences and Health Policies. The same year, he was appointed Director of the Chair of Public Health and Market Access. He launched the first European University Diploma of Market Access (EMAUD)  an international course already followed by about 500 students. Additionally, he recently created the Market Access Society to promote research and scientific activities around market access, public health and health economic assessment. Since 2009, he also chairs the Annual Market Access Day, a purely academic event. He is editor in Chief of the Journal of Market Access and  Health Policy (JMAHP).

Since September 2014, he joined the research unit EA3279 of the public health department, at Aix-Marseille University (France) as full Professor. Mondher Toumi is also visiting Professor at Beijing University (Third Hospital).

He is a recognized expert in health economics and an authority on market access and risk management. He has more than 200 scientific publications and oral communications, and has contributed to several books. He authored a reference book on Market Access.

 

Luca Morreale

Senior Manager Life Sciences

HighPoint Solutions

Luca is a Senior Manager supporting the European Life Sciences team based out of Geneva, Switzerland assisting clients from Big Pharma, Med Device to Mid and Emerging Pharma as relates to Pricing, Contracting and Tendering Strategy, Operations, and Technology.
• Project Manager in the areas of Commercial Excellence, Pricing, Contracting and Tendering
• SME involved in multiple implementations of Tendering, Contracting, GPM, CRM, Business Intelligence as well as territory alignment tools.
• Business analysis, quality assurance and project management for a range of technology platform ranging from Salesforce, Veeva Vault to SharePoint or Model N Flex.
• Led and published the first major industry benchmarking study on Tendering within Life Sciences.

Paolo Correale

Director, Leader of Tefen Life Sciences Pricing Practice

Tefen Management Consulting

Paolo is a Director at Tefen Europe and the Leader of Tefen’s Life Sciences pricing practice. He has been working as a consultant in Life Sciences and Healthcare for more than eight years, ranging across most functional areas. Over the past five years, Paolo has focused on designing and implementing Pricing, Market Access and Healthcare Partnership solutions for leading MedTech and Pharma players, at both global and local level.

In particular, he supported several multinationals in launching processes, organization and technology to manage all aspects of Pricing, from strategy to execution. His current interest is pioneering innovative pricing models and integrated product-service solutions across the care continuum, facilitating partnerships among Life Sciences companies, Healthcare providers and payers.

 

Antonio Pregueiro

VP Life Sciences Europe

HighPoint Solutions

António is a Vice President of Life Sciences and Commercial Excellence solution lead in Europe. António’s experience spans both biotech and pharma, having worked in strategic marketing, commercial operations and analytics.

Most recently António was the head of a Gastroenterology business unit at Takeda, launching the IBD biologic Entyvio and before that was the head of the Business Operations and Implementation group for Europe and Canada. He received a double honors BSc in Genetics and Biochemistry from the University of Sheffield in the UK and a PhD in Genetics from Dartmouth in the US.

Ben Desmet

Senior Manager

Monitor Deloitte Belgium

Ben is Senior Manager at Monitor Deloitte and has 10 years of experience with supporting clients in their business and commercial transformation journey. Ben is member of the EMEA MedTech Center of Excellence with profound knowledge in both price setting and execution.

TESTIMONIALS

Fresenius-Kabi SwissBioSim

Sue Caleo-Naeyaert, Global Head Pricing, Market Access and Policy Biosimilars at Fresenius-Kabi SwissBioSim

“This is a great conference which covers most pricing topics with a decent amount of detail. Anyone can benefit from this conference no matter how experienced”

Ian Tidswell

Ian Tidswell, Founder and Lead Consultant at een Consulting GmbH

The EPP Life Sciences Pricing Forum is a unique event for learning about the latest pricing challenges and techniques to address them, due to the deep experiences and skills of the participants and speakers

BTG

Giuseppe Monita , Senior Manager, Customer Services Contracts & Tendering EMEA at BTG

“Exciting & energetic meeting where it is possible to learn, share & discuss best practices and new ideas on hot topics regarding pricing & tendering” 

Cogentia Healthcare Consulting

David Alderson, Director at Cogentia Healthcare Consulting

“A good event for catching up, great networking and opportunity to share current thinking and best practice” 

Tefen Management Consulting

Chiara Garavaglia, Partner, Global Leader of Tefen Life Sciences Centre of Excellence & Innovation at Tefen Management Consulting

“In my experience, EEP is the only existing opportunity to discuss at 360 degrees about Pricing, involving both pharmaceutical and med tech stakeholders”

Sue Caleo-Naeyaert

Sue Caleo-Naeyaert , Global Head Pricing, Market Access and Policy Biosimilars at Fresenius-Kabi SwissBioSim

“This is a great conference which covers most pricing topics with a decent amount of detail.   Anyone can benefit from this conference no matter how experienced”

 

Henderson Azevedo

Henderson Azevedo, Global Pricing Oncology at Bayer

“A highly recommended forum for pricing professionals”

Alan Crowther

Alan Crowther, President, Global Markets at Alliance Life Sciences Consulting Group

“The 7th EPP Life Sciences Pricing Forum was the 3rd in a row that Alliance Life Sciences attended.  This year’s conference was the best yet in content. Participants come prepared to learn, share and together they helped shape the trends in our industry. The forum on the shores of Lake Geneva at the foot of the Alps is also the best locale you can imagine for a thought-provoking, content-rich conference. What a great atmosphere!”

Chiara Garavaglia

Chiara Garavaglia, Partner, Global Leader at Tefen Management Consulting

“In my experience, EEP is the only existing opportunity to discuss at 360 degrees about Pricing, involving both pharmaceutical and med tech stakeholders”

BD

, at

Baxter Healthcare

, at

Fresenius

, at

GSK

, at

Novo Nordisk

, at

Pfizer

, at

Philips Healthcare

, at

Cardinal Health

, at

Eisai

, at

Alcon

, at

Bristol-Myers Squibb

, at

Bracco Imaging

, at

Creative Ceutical

, at

Ferring

, at

Galderma

, at

GE healthcare

, at

Janssen

, at

Leica microsystems

, at

LFB

, at

Liva Nova

, at

Menarini

, at

NHS

, at

Novartis

, at

RIZIV

, at

Sanofi Aventis

, at

Shire

, at

Smith&Nephew

, at

Terumo

, at

TEVA

, at

UCB

, at

Tillots

, at

Meet pricing decision makers from:

VENUE

CONTENT

Biosimilar pricing in Europe

When a biosimilar enters the market, the reference drug tends to drop in price in the face of competition, whether through internal or external reference pricing or health technology assesment. 

How to eat the value based procurement elephant ?

Procurement in the health care sector is clearly moving towards procurement of “Value”. In this context, it needs no saying Value-based Procurement will be high on the agenda of both health care providers and suppliers for at least the next few years.

How advanced analytics can help spot price optimization opportunities for a large portfolio of products across different markets

How advanced analytics can help spot price optimization opportunities for a large portfolio of products across different markets

by Halima Benghabrit, Global Pricing Director, Sanofi

Alternative pricing models for the future – Analysis of alternative pricing models such as pay for performance, risk sharing and subscriptions

Alternative pricing models for the future – Analysis of alternative pricing models such as pay for performance, risk sharing and subscriptions

by Finn Ziegler, Director, Global Patient Access, LEO Pharma

New types of contracts to obtain a fair reimbursement of your products

New types of contracts to obtain a fair reimbursement of your products

by Youssef Mamour – CPM, EMEA Pricing Director, Getinge

Download your content here !

We hope you enjoy the content.

EPP PARTNERSHIPS

For more info please contact Britt.dejager@pricingplatform.eu

MEDIA PARTNERS